149 related articles for article (PubMed ID: 33846772)
1. TrkB/C-induced HOXC6 activation enhances the ADAM8-mediated metastasis of chemoresistant colon cancer cells.
Park GB; Choi S; Yoon YS; Kim D
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846772
[TBL] [Abstract][Full Text] [Related]
2. A disintegrin and metalloproteinase 8 induced epithelial-mesenchymal transition to promote the invasion of colon cancer cells via TGF-β/Smad2/3 signalling pathway.
Jin Q; Jin X; Liu T; Lu X; Wang G; He N
J Cell Mol Med; 2020 Nov; 24(22):13058-13069. PubMed ID: 32954649
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.
Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y
Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655
[TBL] [Abstract][Full Text] [Related]
4. ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.
Conrad C; Benzel J; Dorzweiler K; Cook L; Schlomann U; Zarbock A; Slater EP; Nimsky C; Bartsch JW
Clin Sci (Lond); 2019 Jan; 133(1):83-99. PubMed ID: 30635388
[TBL] [Abstract][Full Text] [Related]
5. Propofol affects the growth and metastasis of pancreatic cancer via ADAM8.
Yu X; Shi J; Wang X; Zhang F
Pharmacol Rep; 2020 Apr; 72(2):418-426. PubMed ID: 32048249
[TBL] [Abstract][Full Text] [Related]
6. HomeoboxC6 promotes metastasis by orchestrating the DKK1/Wnt/β-catenin axis in right-sided colon cancer.
Qi L; Chen J; Zhou B; Xu K; Wang K; Fang Z; Shao Y; Yuan Y; Zheng S; Hu W
Cell Death Dis; 2021 Apr; 12(4):337. PubMed ID: 33795652
[TBL] [Abstract][Full Text] [Related]
7. Expression levels of the metalloproteinase ADAM8 critically regulate proliferation, migration and malignant signalling events in hepatoma cells.
Awan T; Babendreyer A; Mahmood Alvi A; Düsterhöft S; Lambertz D; Bartsch JW; Liedtke C; Ludwig A
J Cell Mol Med; 2021 Feb; 25(4):1982-1999. PubMed ID: 33314720
[TBL] [Abstract][Full Text] [Related]
8. ADAM8 promotes chondrosarcoma cell migration and invasion by activating the NF-κB/MMP-13 signaling axis.
Liu Y; Li ZH; Zhang L; Lu SB
Anticancer Drugs; 2019 Aug; 30(7):e0790. PubMed ID: 31305294
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer.
Yuan Y; Ye HQ; Ren QC
Int J Oncol; 2018 Feb; 52(2):461-472. PubMed ID: 29345295
[TBL] [Abstract][Full Text] [Related]
10. TLR4-mediated galectin-1 production triggers epithelial-mesenchymal transition in colon cancer cells through ADAM10- and ADAM17-associated lactate production.
Park GB; Kim D
Mol Cell Biochem; 2017 Jan; 425(1-2):191-202. PubMed ID: 27837433
[TBL] [Abstract][Full Text] [Related]
11. Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells.
Lawn S; Krishna N; Pisklakova A; Qu X; Fenstermacher DA; Fournier M; Vrionis FD; Tran N; Chan JA; Kenchappa RS; Forsyth PA
J Biol Chem; 2015 Feb; 290(6):3814-24. PubMed ID: 25538243
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory macrophages activate invasion in pancreatic adenocarcinoma by increasing the MMP9 and ADAM8 expression.
Puolakkainen P; Koski A; Vainionpää S; Shen Z; Repo H; Kemppainen E; Mustonen H; Seppänen H
Med Oncol; 2014 Mar; 31(3):884. PubMed ID: 24526468
[TBL] [Abstract][Full Text] [Related]
13. HOXC6 promotes gastric cancer cell invasion by upregulating the expression of MMP9.
Chen SW; Zhang Q; Xu ZF; Wang HP; Shi Y; Xu F; Zhang WJ; Wang P; Li Y
Mol Med Rep; 2016 Oct; 14(4):3261-8. PubMed ID: 27573865
[TBL] [Abstract][Full Text] [Related]
14. Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer.
Kawamoto M; Onishi H; Ozono K; Yamasaki A; Imaizumi A; Kamakura S; Nakano K; Oda Y; Sumimoto H; Nakamura M
Oncotarget; 2017 May; 8(22):36211-36224. PubMed ID: 28423707
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of microRNA-141 suppresses epithelial-mesenchymal transition and lymph node metastasis in laryngeal cancer through HOXC6-dependent TGF-β signaling pathway.
Chen L; Sun DZ; Fu YG; Yang PZ; Lv HQ; Gao Y; Zhang XY
Cell Signal; 2020 Feb; 66():109444. PubMed ID: 31629025
[TBL] [Abstract][Full Text] [Related]
16. ADAM8 as a drug target in pancreatic cancer.
Schlomann U; Koller G; Conrad C; Ferdous T; Golfi P; Garcia AM; Höfling S; Parsons M; Costa P; Soper R; Bossard M; Hagemann T; Roshani R; Sewald N; Ketchem RR; Moss ML; Rasmussen FH; Miller MA; Lauffenburger DA; Tuveson DA; Nimsky C; Bartsch JW
Nat Commun; 2015 Jan; 6():6175. PubMed ID: 25629724
[TBL] [Abstract][Full Text] [Related]
17. ADAM8 expression in breast cancer derived brain metastases: Functional implications on MMP-9 expression and transendothelial migration in breast cancer cells.
Conrad C; Götte M; Schlomann U; Roessler M; Pagenstecher A; Anderson P; Preston J; Pruessmeyer J; Ludwig A; Li R; Kamm RD; Ritz R; Carl B; Nimsky C; Bartsch JW
Int J Cancer; 2018 Feb; 142(4):779-791. PubMed ID: 28986926
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.
Park GB; Kim D
Mol Cell Biochem; 2018 Feb; 439(1-2):199-211. PubMed ID: 28819788
[TBL] [Abstract][Full Text] [Related]
19. ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer.
Valkovskaya N; Kayed H; Felix K; Hartmann D; Giese NA; Osinsky SP; Friess H; Kleeff J
J Cell Mol Med; 2007; 11(5):1162-74. PubMed ID: 17979891
[TBL] [Abstract][Full Text] [Related]
20. Metalloprotease inhibitor profiles of human ADAM8 in vitro and in cell-based assays.
Schlomann U; Dorzweiler K; Nuti E; Tuccinardi T; Rossello A; Bartsch JW
Biol Chem; 2019 May; 400(6):801-810. PubMed ID: 30738011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
